These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 203231)

  • 21. [Cytostatic therapy of psoriasis].
    Groth O
    Lakartidningen; 1979 Oct; 76(43):3770-1. PubMed ID: 583353
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapy of psoriasis 1975.
    Van Scott EJ
    JAMA; 1976 Jan; 235(2):197-8. PubMed ID: 946030
    [No Abstract]   [Full Text] [Related]  

  • 23. An appraisal of current systemic chemotherapy for psoriasis.
    Farber EM; Pearlman D; Abel EA
    Arch Dermatol; 1976 Nov; 112 Spec no():1679-88. PubMed ID: 793537
    [No Abstract]   [Full Text] [Related]  

  • 24. Abortifacient and teratogenic effects of triacetyl-6-azauridine in the monkey.
    van Wagenen G; DeConti RC; Handschumacher RE; Wade ME
    Am J Obstet Gynecol; 1970 Sep; 108(2):272-81. PubMed ID: 4952580
    [No Abstract]   [Full Text] [Related]  

  • 25. Nucleoside analogs in the treatment of nonneoplastic diseases.
    Calabresi P; Doolittle CH; Heppner GH; McDonald CJ
    Ann N Y Acad Sci; 1975 Aug; 255():190-201. PubMed ID: 1059354
    [No Abstract]   [Full Text] [Related]  

  • 26. Cutaneous uses of the antiproliferative drugs.
    McDonald CJ
    Clin Pharmacol Ther; 1974 Nov; 16(5 Part 2):934-9. PubMed ID: 4138632
    [No Abstract]   [Full Text] [Related]  

  • 27. New indications for 6-azauridine treatment in man. A review.
    Elis J; Rasková H
    Eur J Clin Pharmacol; 1972 Mar; 4(2):77-81. PubMed ID: 4570456
    [No Abstract]   [Full Text] [Related]  

  • 28. Psoriasis: a review. II.
    Baker H
    Dermatologica; 1975; 150(3):136-53. PubMed ID: 1098945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. THE EFFECT OF TRIACETYL AZAURIDINE ON PSORIASIS.
    TURNER RW; CALABRESI P
    J Invest Dermatol; 1964 Dec; 43():551-7. PubMed ID: 14234861
    [No Abstract]   [Full Text] [Related]  

  • 30. High-resolution chromatography provides the answer to the 15-year-old problem of azaribine toxicity.
    Kovach JS
    J Lab Clin Med; 1977 Nov; 90(5):771-2. PubMed ID: 578520
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunosuppressive agents in the treatment of psoriasis].
    Ruszczak Z
    Vestn Dermatol Venerol; 1976 Jan; (1):35-40. PubMed ID: 997862
    [No Abstract]   [Full Text] [Related]  

  • 32. Hydrolysis of the prodrug, 2',3',5'-triacetyl-6-azauridine.
    Riley CM; Mummert MA; Zhou J; Schowen RL; Vander Velde DG; Morton MD; Slavik M
    Pharm Res; 1995 Sep; 12(9):1361-70. PubMed ID: 8570536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azaribine, homocystinemia, and thrombosis.
    Shupack JL; Grieco AJ; Epstein AM; Sansaricq C; Snyderman SE
    Arch Dermatol; 1977 Sep; 113(9):1301-2. PubMed ID: 578401
    [No Abstract]   [Full Text] [Related]  

  • 34. Beneficial effects of triacetyl azauridine in psoriasis and mycosis fungoides.
    Calabresi P; Turner RW
    Ann Intern Med; 1966 Feb; 64(2):352-71. PubMed ID: 5902280
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro metabolism studies of the prodrug, 2',3',5'-triacetyl-6-azauridine, utilizing an automated analytical system.
    Zhou J; Riley CM; Schowen RL
    J Pharm Biomed Anal; 2001 Dec; 26(5-6):701-16. PubMed ID: 11600283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azaribine-homocystinemia-thrombosis in historical perspective.
    Drell W; Welch AD
    Pharmacol Ther; 1989; 41(1-2):195-206. PubMed ID: 2469090
    [No Abstract]   [Full Text] [Related]  

  • 37. Conformation of pyridazine nucleosides: the molecular structure of 4-hydroxy-1-(beta-D-ribofuranosyl)pyridazin-6-one (3-deaza-6-azauridine).
    Graves BJ; Hodgson DJ; Katz DJ; Wise DS; Townsend LB
    Biochim Biophys Acta; 1978 Aug; 520(1):229-32. PubMed ID: 698230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Automated analytical systems for drug development studies. V. A system for enzyme kinetic studies.
    Zhou J; Shearer EC; Hong J; Riley CM; Schowen RL
    J Pharm Biomed Anal; 1996 Sep; 14(12):1691-8. PubMed ID: 8887716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-response curves in the evaluation of the clinical efficacy of drugs.
    Jankú I; Elis J; Rasková H
    Eur J Clin Pharmacol; 1971 Sep; 3(4):194-7. PubMed ID: 5151302
    [No Abstract]   [Full Text] [Related]  

  • 40. Decrease of serum pyridoxal phosphate levels and homocystinemia after administration of 6-azauridine triacetate and their prevention by administration of pyridoxine.
    Slavik M; Smith KJ; Blanc O
    Biochem Pharmacol; 1982 Dec; 31(24):4089-92. PubMed ID: 6186258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.